Maximilian Diehn
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC (NCT04585490) | Maximilian Diehn | 2021-08-25 |
Track Maximilian Diehn automatically
Every clearance here is in the API, with alerts when new ones post.